MX2009007045A - Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich. - Google Patents

Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich.

Info

Publication number
MX2009007045A
MX2009007045A MX2009007045A MX2009007045A MX2009007045A MX 2009007045 A MX2009007045 A MX 2009007045A MX 2009007045 A MX2009007045 A MX 2009007045A MX 2009007045 A MX2009007045 A MX 2009007045A MX 2009007045 A MX2009007045 A MX 2009007045A
Authority
MX
Mexico
Prior art keywords
muscular dystrophy
treatment
congenital muscular
ullrich congenital
immunosuppressive cyclosporin
Prior art date
Application number
MX2009007045A
Other languages
English (en)
Spanish (es)
Inventor
Gregoire Vuagniaux
Paolo Bernardi
Rafael Crabbe
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Publication of MX2009007045A publication Critical patent/MX2009007045A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2009007045A 2007-01-04 2008-01-03 Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich. MX2009007045A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87841407P 2007-01-04 2007-01-04
PCT/IB2008/000003 WO2008084368A2 (en) 2007-01-04 2008-01-03 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy

Publications (1)

Publication Number Publication Date
MX2009007045A true MX2009007045A (es) 2009-10-07

Family

ID=39514754

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007045A MX2009007045A (es) 2007-01-04 2008-01-03 Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich.

Country Status (12)

Country Link
US (1) US8450281B2 (https=)
EP (1) EP2124992A2 (https=)
JP (1) JP5801534B2 (https=)
CN (2) CN105056207A (https=)
AU (1) AU2008204344B2 (https=)
BR (1) BRPI0806265A2 (https=)
CA (1) CA2674296C (https=)
HK (1) HK1210951A1 (https=)
IL (1) IL199674A (https=)
MX (1) MX2009007045A (https=)
RU (1) RU2462262C2 (https=)
WO (1) WO2008084368A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
US9119853B2 (en) 2010-02-09 2015-09-01 Neurovive Pharmaceutical Ab Sanglifehrin based compounds
WO2011098805A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
WO2011098808A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
GB201008123D0 (en) 2010-05-17 2010-06-30 Biotica Tech Ltd Novel compounds
JP6086869B2 (ja) 2010-12-20 2017-03-08 ネウロビベ プハルマセウトイカル エービー サングリフェリン誘導体及びそれらの製造方法
JO3063B1 (ar) 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab مركب مبتكر وطرق لانتاجه
JP2015516423A (ja) 2012-05-07 2015-06-11 ノバルティス アーゲー アリスポリビルによる薬物動態の調節
AR090964A1 (es) 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3884470T2 (de) * 1987-06-17 1994-03-10 Sandoz Ag Cyclosporine und deren Benutzung als Arzneimittel.
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
WO1999055321A1 (en) * 1998-04-24 1999-11-04 Mitokor Compounds and methods for treating mitochondria-associated diseases
AU759480B2 (en) * 1998-07-01 2003-04-17 Debiopharm S.A. Novel cyclosporin with improved activity profile
US6323039B1 (en) * 1999-06-22 2001-11-27 Mitokor Compositions and methods for assaying subcellular conditions and processes using energy transfer
US7368423B1 (en) 2001-12-05 2008-05-06 The Scripps Research Institute Composition and method for treating chronic allograft rejection
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy

Also Published As

Publication number Publication date
WO2008084368A9 (en) 2009-02-26
AU2008204344A1 (en) 2008-07-17
CN105056207A (zh) 2015-11-18
RU2462262C2 (ru) 2012-09-27
BRPI0806265A2 (pt) 2011-09-06
EP2124992A2 (en) 2009-12-02
AU2008204344A9 (en) 2012-06-28
AU2008204344B2 (en) 2013-01-31
US8450281B2 (en) 2013-05-28
CN101616683A (zh) 2009-12-30
HK1210951A1 (en) 2016-05-13
CA2674296C (en) 2015-11-24
US20100041593A1 (en) 2010-02-18
IL199674A0 (en) 2010-04-15
JP5801534B2 (ja) 2015-10-28
JP2010514834A (ja) 2010-05-06
WO2008084368A2 (en) 2008-07-17
CA2674296A1 (en) 2008-07-17
IL199674A (en) 2016-10-31
WO2008084368A8 (en) 2009-09-17
RU2009129212A (ru) 2011-02-10

Similar Documents

Publication Publication Date Title
MX2009007045A (es) Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich.
MX2010006025A (es) Analogo de pterina para tratar afeccion sensible a bh4.
MX2009009428A (es) Analogos de ciclopamina heterociclicos y metodos de uso de los mismos.
PH12013501215A1 (en) Glucagon analogs exhibiting gip receptor activity
GEP20156329B (en) CHEMICAL MODIFICATIONS OF miRNA INHIBITORS AND MIMETICS
MX355543B (es) Macrociclos peptidomiméticos.
MY181898A (en) Heterocyclic compounds and uses thereof
MX2009009153A (es) Pirano-pirazol-aminas.
EP2595482A4 (en) ALDOSTERONSYNTHASEHEMMER
SG178999A1 (en) Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
MX2012004624A (es) Metodos para tratar canceres positivos para el receptor de androgenos.
MX2009009154A (es) Derivados de espiro-pirano-pirazol.
MY150600A (en) Use of opioid antagonists for treating urinary retention
TN2012000581A1 (en) Piperidinyl compound as a modulator of chemokine receptor activity
MY151104A (en) Novel use
MX2013004062A (es) Analogos de ciclosporina.
EP4070794A3 (en) Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders
MX2010007669A (es) Metodos para inhibir la angiogenesis utilizando antagonistas de egfl8.
MX2010004814A (es) Metodos para tratar esclerodermia.
ZA201005483B (en) Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy
EP3345596A3 (en) Inhibitors of beta-hydrolase for treatment of cancer
MX2012015112A (es) Uso de antagonistas del receptor de adenosina a2b para el tratamiento de la hipertension pulmonar.
WO2011091410A8 (en) Trpv4 antagonists
PE20130603A1 (es) Composicion farmaceutica que contiene un inhibidor de esteroide c17,20 liasa
WO2010080577A3 (en) Oxepine modulators of h1 receptors and/or inhibitors of mast cell degranulation

Legal Events

Date Code Title Description
FG Grant or registration